Bristol Myers Squibb (BMY) Amortization - Intangibles (2019 - 2026)

Bristol Myers Squibb (BMY) has reported Amortization - Intangibles for 8 consecutive years, with $437.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Amortization - Intangibles fell 47.35% year-over-year to $437.0 million in Q2 2026; TTM through Jun 2026 was $2.5 billion, a 56.05% decrease from a year earlier, with the FY2025 full-year figure at $3.3 billion, down 62.61% from the prior year.
• Amortization - Intangibles was $437.0 million for Q2 2026 at Bristol Myers Squibb, roughly flat from $437.0 million in the prior quarter.
• Over five years, Amortization - Intangibles peaked at $2.4 billion in Q3 2022 and troughed at $437.0 million in Q1 2026.
• A 5-year average of $1.8 billion and a median of $2.3 billion in 2023 frame the typical range for Amortization - Intangibles.
• Across the five-year window, Amortization - Intangibles increased 7.04% in 2024 and tumbled 65.65% in 2025, its largest moves.
• Over 5 years, Amortization - Intangibles stood at $2.3 billion in 2022, then slipped by 2.77% to $2.3 billion in 2023, then decreased by 25.68% to $1.7 billion in 2024, then sank by 51.21% to $826.0 million in 2025, then sank by 47.09% to $437.0 million in 2026.
• The last three Amortization - Intangibles figures came in at $437.0 million (Q2 2026), $437.0 million (Q1 2026), and $826.0 million (Q4 2025), per Business Quant data.